Drug name - Lorbrena

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8680111 PFIZER Macrocyclic derivatives for the treatment of diseases
Mar, 2033

(10 years from now)

US10420749 PFIZER Crystalline form of lorlatinib free base
Jul, 2036

(13 years from now)

CN104169286A PFIZER Macrocyclic Derivative For Treating Proliferative Diseases
Feb, 2033

(10 years from now)

CN104169286B PFIZER Macrocyclic Derivative For Treating Proliferative Diseases
Feb, 2033

(10 years from now)

IN201407205P4 PFIZER Macrocyclic Derivatives For The Treatment Of Proliferative Diseases
Feb, 2033

(10 years from now)

IN298989B PFIZER Macrocyclic Derivatives For The Treatment Of Proliferative Diseases
Feb, 2033

(10 years from now)

EP2822953B1 PFIZER Macrocyclic Derivatives For The Treatment Of Proliferative Diseases
Feb, 2033

(10 years from now)

EP2822953A1 PFIZER Macrocyclic Derivatives For The Treatment Of Proliferative Diseases
Feb, 2033

(10 years from now)

EP2822953B9 PFIZER Macrocyclic Derivatives For The Treatment Of Proliferative Diseases
Feb, 2033

(10 years from now)

EP3328867A1 PFIZER Crystalline Form Of Lorlatinib Free Base
Jul, 2036

(13 years from now)

EP3328867B1 PFIZER Crystalline Form Of Lorlatinib Free Base
Jul, 2036

(13 years from now)

EP3328867B9 PFIZER Crystalline Form Of Lorlatinib Free Base
Jul, 2036

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11020376 PFIZER Crystalline form of lorlatinib free base Jul, 2036

(13 years from now)

Drugs and Companies using LORLATINIB ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
25MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.